... mechanism for eliminating poorly made ones.
Mantle cell lymphoma, an aggressive cancer of the lymphatic system ... keep their fast pace, these now-malignant cells need increased activity of heat shock ...
... at NewYork-Presbyterian/Columbia, now focusing on determining how the drug works in T-cell lymphoma, and on how best to combine it with other drugs to improve the treatment of patient with ...
... works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma.
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as front-line treatment remain in remission seven years later, researchers have reported.
HOUSTON, Dec. 15 (UPI) -- U.S. medical scientists say they've found indolent B cell lymphoma patients respond well to a new three-drug combination therapy.
... are two types of lymphoma: B cell lymphomas and T cell lymphomas. Both B cells ... determined how the most common chromosomal translocation in B cell lymphoma occurs. Researchers at USC have been working ...
WASHINGTON, Sept. 28 (UPI) -- The U.S. Food and Drug Administration has approved Folotyn as the first treatment for a form of cancer known as peripheral T-cell lymphoma.
Scientists have demonstrated that misregulation of the protein SPAK may contribute to B-cell lymphoma development.
... . "The mouse we created gives us a very good, predictive model of B-cell lymphomas, which can be used to explore not only these and related cancers, but also autoimmune disease and basic immunology."
... incurable.
To determine how many people have been diagnosed with mantle cell lymphoma since it was first recognized, Dr ... 13 years is unknown.
Because mantle cell lymphoma often goes undetected until ...
... polyposis (MLP) is an unusual form mantle cell lymphoma characterized by polyps throughout the gastrointestinal ... a malignancy associated with retrovirus, human T-cell lymphotropic virus type 1 (HTLV-1 ...
... approximately 66,000 new cases of lymphoma and nearly 20,000 deaths each ... patients with relapsed or refractory peripheral T-cell lymphoma, found that the investigational chemotherapy agent pralatrexate ...
... lead researcher on the Mayo study.
"One in five lymphoma patients take cholesterol-lowering statins; ... patients. For patients with diffuse large B-cell lymphoma, statin use did not influence outcomes ...
... three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially ... long-term myelosuppression for indolent B cell lymphoma patients is myelodysplastic syndrome," Samaniego ...
(PhysOrg.com) -- Using cancer cells that were originally isolated from an anaplastic large cell lymphoma patient, two researchers, including a faculty member of The University of Texas at Austin's ...
